Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cervical Vertebrae | 7 | 2025 | 117 | 2.960 |
Why?
|
| Neurosurgery | 2 | 2025 | 75 | 1.070 |
Why?
|
| Thoracic Vertebrae | 2 | 2025 | 67 | 1.070 |
Why?
|
| Arnold-Chiari Malformation | 3 | 2024 | 55 | 1.060 |
Why?
|
| Stereotaxic Techniques | 1 | 2026 | 98 | 0.910 |
Why?
|
| Joint Dislocations | 1 | 2024 | 23 | 0.860 |
Why?
|
| Auditory Brain Stem Implantation | 1 | 2024 | 1 | 0.850 |
Why?
|
| Audiometry | 1 | 2024 | 22 | 0.840 |
Why?
|
| Joint Instability | 1 | 2024 | 57 | 0.820 |
Why?
|
| Neurofibromatosis 1 | 1 | 2024 | 67 | 0.820 |
Why?
|
| Spinal Fusion | 4 | 2025 | 118 | 0.800 |
Why?
|
| Scoliosis | 1 | 2024 | 145 | 0.770 |
Why?
|
| Neurosurgical Procedures | 2 | 2022 | 317 | 0.760 |
Why?
|
| Electroencephalography | 1 | 2026 | 875 | 0.680 |
Why?
|
| Craniopharyngioma | 3 | 2025 | 34 | 0.610 |
Why?
|
| Pituitary Neoplasms | 3 | 2025 | 78 | 0.580 |
Why?
|
| Epilepsy | 1 | 2026 | 898 | 0.550 |
Why?
|
| Glioma | 1 | 2021 | 500 | 0.500 |
Why?
|
| Bibliometrics | 2 | 2025 | 39 | 0.440 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 1300 | 0.420 |
Why?
|
| Occipital Bone | 2 | 2025 | 24 | 0.280 |
Why?
|
| Humans | 26 | 2026 | 131967 | 0.280 |
Why?
|
| Child | 13 | 2025 | 26332 | 0.260 |
Why?
|
| Treatment Outcome | 8 | 2026 | 13011 | 0.250 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2026 | 10 | 0.240 |
Why?
|
| Hydrocephalus | 2 | 2026 | 292 | 0.240 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2026 | 63 | 0.230 |
Why?
|
| Hemispherectomy | 1 | 2025 | 28 | 0.230 |
Why?
|
| Pedicle Screws | 1 | 2025 | 3 | 0.230 |
Why?
|
| Scalp | 1 | 2025 | 58 | 0.230 |
Why?
|
| Atlanto-Axial Joint | 1 | 2025 | 21 | 0.230 |
Why?
|
| Kyphosis | 1 | 2025 | 21 | 0.230 |
Why?
|
| Craniotomy | 1 | 2025 | 102 | 0.220 |
Why?
|
| Range of Motion, Articular | 1 | 2025 | 85 | 0.220 |
Why?
|
| Nerve Block | 1 | 2025 | 64 | 0.220 |
Why?
|
| Cerebral Hemorrhage | 1 | 2026 | 157 | 0.220 |
Why?
|
| Neuroendoscopy | 1 | 2024 | 32 | 0.210 |
Why?
|
| Third Ventricle | 1 | 2024 | 32 | 0.210 |
Why?
|
| Ventriculostomy | 1 | 2024 | 46 | 0.210 |
Why?
|
| Auditory Brain Stem Implants | 1 | 2024 | 2 | 0.210 |
Why?
|
| Cochlear Nerve | 1 | 2024 | 9 | 0.210 |
Why?
|
| Ribs | 1 | 2024 | 55 | 0.200 |
Why?
|
| Adolescent | 8 | 2025 | 21008 | 0.200 |
Why?
|
| Cavernous Sinus | 1 | 2023 | 24 | 0.200 |
Why?
|
| Infant, Premature, Diseases | 1 | 2026 | 255 | 0.200 |
Why?
|
| Pain Management | 1 | 2025 | 203 | 0.200 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2023 | 19 | 0.200 |
Why?
|
| Biomechanical Phenomena | 1 | 2024 | 265 | 0.200 |
Why?
|
| Retrospective Studies | 11 | 2026 | 17703 | 0.200 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2026 | 255 | 0.190 |
Why?
|
| Natural Language Processing | 1 | 2023 | 72 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 3928 | 0.180 |
Why?
|
| Skull Base Neoplasms | 1 | 2022 | 37 | 0.180 |
Why?
|
| Meningitis | 1 | 2022 | 98 | 0.180 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2025 | 268 | 0.180 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 300 | 0.180 |
Why?
|
| Biology | 1 | 2021 | 25 | 0.180 |
Why?
|
| Down Syndrome | 1 | 2024 | 233 | 0.170 |
Why?
|
| Delphi Technique | 1 | 2022 | 264 | 0.170 |
Why?
|
| Technology | 1 | 2021 | 69 | 0.170 |
Why?
|
| Child, Preschool | 7 | 2025 | 15066 | 0.170 |
Why?
|
| Radiography | 1 | 2023 | 762 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2023 | 313 | 0.160 |
Why?
|
| Meningioma | 1 | 2022 | 137 | 0.160 |
Why?
|
| Postoperative Care | 1 | 2022 | 303 | 0.160 |
Why?
|
| Meningeal Neoplasms | 1 | 2022 | 208 | 0.160 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 234 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2025 | 558 | 0.150 |
Why?
|
| Male | 12 | 2026 | 65357 | 0.150 |
Why?
|
| Female | 13 | 2026 | 71316 | 0.150 |
Why?
|
| Dura Mater | 1 | 2018 | 28 | 0.140 |
Why?
|
| Decompression, Surgical | 1 | 2018 | 89 | 0.130 |
Why?
|
| Quality of Life | 2 | 2025 | 2116 | 0.130 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 569 | 0.130 |
Why?
|
| Infant | 4 | 2026 | 13332 | 0.130 |
Why?
|
| Follow-Up Studies | 5 | 2025 | 5298 | 0.120 |
Why?
|
| Physicians | 1 | 2023 | 634 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2023 | 810 | 0.120 |
Why?
|
| Astrocytoma | 1 | 2016 | 102 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2024 | 3135 | 0.100 |
Why?
|
| Histones | 1 | 2016 | 537 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2016 | 347 | 0.090 |
Why?
|
| Brain | 2 | 2023 | 3247 | 0.090 |
Why?
|
| Sulindac | 1 | 2011 | 5 | 0.090 |
Why?
|
| Thiones | 1 | 2011 | 8 | 0.090 |
Why?
|
| Naproxen | 1 | 2011 | 19 | 0.090 |
Why?
|
| Growth Inhibitors | 1 | 2011 | 36 | 0.090 |
Why?
|
| Hydrogen Sulfide | 1 | 2011 | 12 | 0.090 |
Why?
|
| Ibuprofen | 1 | 2011 | 41 | 0.090 |
Why?
|
| Aspirin | 1 | 2011 | 216 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 302 | 0.080 |
Why?
|
| Adult | 4 | 2024 | 31734 | 0.080 |
Why?
|
| Obesity | 1 | 2019 | 2392 | 0.070 |
Why?
|
| Panama | 1 | 2025 | 16 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2026 | 131 | 0.060 |
Why?
|
| Observer Variation | 1 | 2025 | 319 | 0.050 |
Why?
|
| New York City | 1 | 2024 | 64 | 0.050 |
Why?
|
| History, 18th Century | 1 | 2024 | 69 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2483 | 0.050 |
Why?
|
| Autografts | 1 | 2024 | 29 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2024 | 110 | 0.050 |
Why?
|
| Hospitals, Public | 1 | 2024 | 51 | 0.050 |
Why?
|
| Bone Transplantation | 1 | 2024 | 52 | 0.050 |
Why?
|
| Punctures | 1 | 2023 | 60 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2024 | 261 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2024 | 366 | 0.050 |
Why?
|
| Polyethylenes | 1 | 2022 | 7 | 0.050 |
Why?
|
| Methicillin | 1 | 2022 | 43 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2023 | 320 | 0.050 |
Why?
|
| Young Adult | 3 | 2025 | 10108 | 0.050 |
Why?
|
| Titanium | 1 | 2022 | 26 | 0.050 |
Why?
|
| Skull Base | 1 | 2022 | 48 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2023 | 117 | 0.050 |
Why?
|
| Contrast Media | 1 | 2025 | 492 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1812 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2022 | 121 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 206 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2025 | 2148 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2026 | 858 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2023 | 424 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2022 | 485 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2025 | 2992 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2026 | 3453 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1141 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2023 | 1076 | 0.030 |
Why?
|
| Comorbidity | 1 | 2023 | 1607 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2019 | 205 | 0.030 |
Why?
|
| Length of Stay | 1 | 2023 | 1400 | 0.030 |
Why?
|
| Registries | 1 | 2024 | 1598 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2226 | 0.030 |
Why?
|
| Pediatrics | 1 | 2025 | 1239 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 844 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2019 | 1695 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2026 | 8604 | 0.020 |
Why?
|
| Middle Aged | 2 | 2022 | 28911 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2578 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 1281 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6285 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1860 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 3708 | 0.010 |
Why?
|